Adrenal myelolipomas are rare, benign, nonfunctioning tumors composed of mature adipose tissue and scattered hematopoietic elements. Ultrasonography, CT, and MRI are effective in diagnosing adrenal myelolipomas in more than 90% of cases, with CT being the most sensitive diagnostic imaging modality.1Most are asymptomatic and identified incidentally during radiologic studies. The prevalence of an adrenal incidentaloma at autopsy is less than 1% for patients younger than 30 years, but increases to 7% in patients aged 70 years or older.2Differential diagnosis of a fatty adrenal mass includes teratoma, lipoma, liposarcoma, and angiomyolipoma. The incidence of adrenal myelolipomas is 0.03% at autopsy.2Although usually small (<5 cm), they can reach massive size and become symptomatic. Adrenal myelolipomas have been reported to present with abdominal and flank pain, palpable mass, or hematuria that are predominantly the result of tumor necrosis or hemorrhage. While hormonally inactive, these tumors have been reported to coexist with hormonally active conditions such as pheochromocytoma, Cushing syndrome, and congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency.3Extraadrenal myelolipomas have also been reported to occur in approximately 15% of cases, with approximately 50% occurring in the presacral area and the remainder in the thorax, retroperitoneum, pelvis, kidneys, liver, and stomach.3